Category: Uncategorized

Merck and the Mayo Clinic have announced a strategic R&D agreement to integrate artificial intelligence, advanced analytics, and multimodal clinical... Read more

Novartis has entered a multi-billion dollar research collaboration and licensing agreement with Unnatural Products Inc. (UNP) to target historically "undruggable"... Read more

Zifo and Maze Therapeutics have launched a collaboration to develop scalable solutions for managing vast and fragmented biobank datasets. By... Read more

Ibex Medical Analytics, a leader in AI-powered pathology, has announced a strategic leadership transition alongside the expansion of its life... Read more

The U.S. Department of Health and Human Services (HHS) has expanded its partnership with biotech firm Manus, providing an additional... Read more

Pluri Biotech has secured a patent from the China National Intellectual Property Administration (CNIPA) for its proprietary 3D immune cell... Read more

Eli Lilly has entered into a $100 million licensing agreement with CSL Ltd. for clazakizumab, a monoclonal antibody designed to... Read more

The psychedelic medicine sector experienced a broad market rally on February 17, 2026, following breakthrough data from Compass Pathways. The... Read more

The U.S. Food and Drug Administration (FDA) has reversed its earlier stance and will now proceed with the regulatory review... Read more